oxazepam has been researched along with propranolol in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (30.77) | 18.7374 |
1990's | 4 (10.26) | 18.2507 |
2000's | 14 (35.90) | 29.6817 |
2010's | 8 (20.51) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Coassolo, P; Lavé, T; Schneider, G | 1 |
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Caron, G; Ermondi, G | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Briand, X; Faller, B; Lázaro, E; Lowe, PJ | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Courtioux, B; Fairlamb, A; Hutter, S; Laget, M; Moreau, A; Mothes, E; Paloque, L; Pedron, J; Pratviel, G; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vendier, L; Verhaeghe, P; Wyllie, S | 1 |
Bajusz, D; Balogh, GT; Dargó, G; Müller, J; Simon, K | 1 |
Dahlöf, C | 1 |
Døssing, M; Hamberg, O; Loft, S; Olesen, KL; Sonne, J; Thyssen, H; Victor, MA; Vollmer-Larsen, A | 1 |
Dahlöf, C; Dimenäs, E; Olofsson, B | 1 |
McDevitt, DG | 1 |
Currie, D; Lewis, RV; McDevitt, DG; Nicholson, AN; Wright, NA | 1 |
Currie, D; McDevitt, DG; Nicholson, AN; Wright, NA; Zetlein, MB | 1 |
Naess, K | 1 |
Erkkola, R; Iisalo, E; Punnonen, R | 2 |
Berger, BD; Stein, L; Wise, CD | 1 |
Kulik, AV; Wilbur, R | 1 |
Goch, JH; Kowalski, J; Tkaczewski, W; Wichan, P | 1 |
Davis, JM; Dysken, MW; Hicks, R; Lazarus, L; Lesser, J; Ripeckyj, A | 1 |
Coffman, BL; King, CD; Rios, GR; Tephly, TR | 1 |
Juvonen, R; Korhonen, LE; Pelkonen, O; Raunio, H; Tolonen, A; Turpeinen, M; Uusitalo, J | 1 |
Billiot, E; Billiot, F; Warner, IM | 1 |
3 review(s) available for oxazepam and propranolol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The pharmacokinetics of psychotropic medication in the elderly: a review.
Topics: Aged; Alcoholism; Analgesics; Antidepressive Agents, Tricyclic; Barbiturates; Biological Availability; Biotransformation; Chlorpromazine; Drug Interactions; Flurazepam; Humans; Intestinal Absorption; Kidney; Kinetics; Lithium; Monoamine Oxidase Inhibitors; Nitrazepam; Oxazepam; Parasympatholytics; Physostigmine; Propranolol; Psychotropic Drugs; Tobacco Use Disorder | 1981 |
7 trial(s) available for oxazepam and propranolol
Article | Year |
---|---|
Single dose pharmacokinetics and pharmacodynamics of oral oxazepam during concomitant administration of propranolol and labetalol.
Topics: Adult; Drug Interactions; Female; Humans; Labetalol; Male; Oxazepam; Propranolol; Psychomotor Performance; Reaction Time | 1990 |
Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.
Topics: Brain; Cardiovascular Agents; Double-Blind Method; Humans; Oxazepam; Propranolol; Reproducibility of Results; Surveys and Questionnaires | 1989 |
Beta-blockers and psychometric performance: studies in normal volunteers.
Topics: Adrenergic beta-Antagonists; Atenolol; Diazepam; Dose-Response Relationship, Drug; Humans; Lipid Metabolism; Nadolol; Oxazepam; Propanolamines; Propranolol; Psychometrics; Psychomotor Performance; Random Allocation; Reaction Time; Reference Values; Solubility; Time Factors | 1985 |
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Attention; Double-Blind Method; Electroencephalography; Emotions; Flicker Fusion; Heart Rate; Humans; Male; Memory, Short-Term; Oxazepam; Propranolol; Psychomotor Performance; Random Allocation; Reaction Time | 1988 |
Central effects of beta-adrenoceptor antagonists. II--Electroencephalogram and body sway.
Topics: Adrenergic beta-Antagonists; Atenolol; Electroencephalography; Humans; Oxazepam; Postural Balance; Propranolol | 1988 |
The effect of propranolol and oxazepam on some vegetative menopausal symptoms.
Topics: Adult; Blood Pressure; Castration; Depression, Chemical; Electrocardiography; Female; Heart Rate; Humans; Menopause; Oxazepam; Propranolol; Sweating; Sympathetic Nervous System; Valsalva Maneuver | 1973 |
[Ergometric test in sympatheticotonia after administration of propranolol, pindolol, verapamil and oxazepam].
Topics: Adolescent; Adrenergic Fibers; Adult; Clinical Trials as Topic; Exercise Test; Heart; Heart Failure; Humans; Male; Oxazepam; Pindolol; Propranolol; Verapamil | 1980 |
29 other study(ies) available for oxazepam and propranolol
Article | Year |
---|---|
Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques.
Topics: Animals; Biological Availability; Dogs; Humans; Least-Squares Analysis; Liver; Multivariate Analysis; Neural Networks, Computer; Pharmacokinetics; Rats | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
New approach to measure protein binding based on a parallel artificial membrane assay and human serum albumin.
Topics: Humans; Kinetics; Membranes, Artificial; Permeability; Protein Binding; Serum Albumin | 2008 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
Topics: Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Electrochemical Techniques; Hep G2 Cells; Humans; Kinetoplastida; Leishmania infantum; Molecular Structure; Nitroquinolines; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma brucei brucei | 2018 |
Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design.
Topics: Binding Sites; Chemistry, Pharmaceutical; Drug Design; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Pharmaceutical Preparations; Protein Binding; Serum Albumin, Human; Spectrophotometry, Ultraviolet; Titrimetry | 2020 |
Minor Symptoms Evaluation (MSE) Profile--a questionnaire for assessment of subjective CNS-related symptoms.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzodiazepines; Central Nervous System Diseases; Health Status; Humans; Migraine Disorders; Oxazepam; Propranolol; Quality of Life; Reproducibility of Results; Surveys and Questionnaires | 1990 |
Beta-blockers, mood and behaviour.
Topics: Adult; Affect; Atenolol; Humans; Male; Memory, Short-Term; Oxazepam; Propranolol; Psychomotor Performance | 1988 |
[Brief characteristics of different "sedatives"].
Topics: Anthracenes; Antidepressive Agents; Benzodiazepinones; Chlordiazepoxide; Diazepam; Hypnotics and Sedatives; Meprobamate; Oxazepam; Propranolol; Tranquilizing Agents | 1974 |
Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain.
Topics: Animals; Anxiety; Behavior, Animal; Benzazepines; Brain; Depression, Chemical; Dopamine; Drug Antagonism; Drug Interactions; Humans; Hydroxyindoleacetic Acid; Norepinephrine; Normetanephrine; Oxazepam; Phenothiazines; Phentolamine; Propranolol; Rats; Reinforcement Schedule; Serotonin; Serotonin Antagonists | 1972 |
The effect of bilateral ovarectomy on sympathetic cardiovascular reflexes and the treatment of the postoperative vegetative syndrome with propranolol and oxazepam.
Topics: Blood Pressure; Castration; Female; Heart Rate; Humans; Middle Aged; Oxazepam; Propranolol; Tachycardia; Valsalva Maneuver; Vasomotor System | 1971 |
Abstinence syndrome from therapeutic doses of oxazepam.
Topics: Adult; Anxiety; Depression; Depressive Disorder; Diazepam; Fasciculation; Fear; Humans; Male; Oxazepam; Panic; Paresthesia; Propranolol; Substance Withdrawal Syndrome | 1983 |
The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268).
Topics: Androgens; Androsterone; Cell Line; Gene Expression; Glucuronates; Glucuronosyltransferase; Humans; Isoenzymes; Kinetics; Menthol; Narcotics; Oxazepam; Propranolol; Recombinant Proteins; Xenobiotics | 1998 |
Cytochrome P450 (CYP) inhibition screening: comparison of three tests.
Topics: Citalopram; Cytochrome P-450 Enzyme Inhibitors; Diazepam; Enzyme Inhibitors; Fluoxetine; Humans; Oxazepam; Propranolol; Sotalol | 2006 |
Optimization of 12 chiral analytes with 8 polymeric surfactants.
Topics: Alprenolol; Amino Acids; Benzodiazepinones; Buffers; Diamines; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Lorazepam; Naphthalenes; Naphthols; Organophosphates; Oxazepam; Oxprenolol; Propanolamines; Propranolol; Stereoisomerism; Surface-Active Agents; Temazepam | 2008 |